Skip to main content
. 2022 Jul 5;12:267. doi: 10.1038/s41398-022-02027-4

Fig. 3. Network meta-analyses of all the strategies in treatment of patients with antipsychotic-induced hyperprolactinemia.

Fig. 3

A Network plot and league table of comparison of all the strategies in treatment of patients with antipsychotic-induced hyperprolactinemia; B network plot and league table of comparison of all re-divided strategies in treatment of patients with antipsychotic-induced hyperprolactinemia. ARI adjunctive aripiprazole, DA adjunctive dopamine agonist, MET adjunctive metformin, PGD adjunctive Peony-Glycyrrhiza decoction, Switching switch to another antipsychotic, VitB6 adjunctive high-dose vitamin B6. ARI_5 mg adjunctive 5 mg aripiprazole, ARI_10 mg adjunctive 10 mg aripiprazole, ARI_more_10 mg adjunctive more than 10 mg aripiprazole, switch_ARI_fixed_im switching to ARI with fixed dosage and reducing the previous antipsychotic immediately, switch_ARI_fixed_ta switching to ARI with fixed dosage and reducing the previous antipsychotic in tardation, switch_ARI_ti_ta switching to ARI in titration and reducing the previous antipsychotic in tardation, switch_OLA switching to olanzapine, switch_QUE switching to quetiapine. The color of each cell indicates the certainty of evidence according to the Grading of Recommendations Assessment, Development, and Evaluation. Red color refers to very low certainty of evidence, yellow color refers to low certainty of evidence, green color refers to moderate certainty of evidence, blue color refers to high certainty of evidence. The significant outcomes were shown in bold.